Business Standard

Saturday, December 21, 2024 | 04:19 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

With GSK buy, HUL also wins access to key pharmacy channels in India

Beauty and personal care sales contribution coming from the pharmacy channel is pegged at around 15-20%

Chart
Premium

Viveat Susan Pinto Mumba
Hindustan Unilever (HUL) acquiring GlaxoSmithKline (GSK) Consumer will not only give the Indian consumer goods company a portfolio of health food drinks such as Horlicks and Boost but also access to the key pharmacy channel in the country.

According to the deal announced on Monday, HUL has decided to undertake distribution of GSK Consumer’s over-the-counter (OTC) products, including Iodex, Eno, Crocin, and Sensodyne, for a period of five years.

These products were earlier distributed by GSK Consumer as part of an arrangement with its parent, which owned the brands. While GSK will continue to own these brands (they are not part of

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in